1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. New Jersey >
  6. Intra-Cellular Therapies

Intra-Cellular Therapies - Ownership and Business Overview

Life ScienceCompany

Intra-Cellular Therapies Ownership

Who owns Intra-Cellular Therapies?

Intra-Cellular Therapies is owned by Johnson & Johnson. It was acquired on January 13, 2025.

Intra-Cellular Therapies Business Overview

Where is Intra-Cellular Therapies headquartered?

Intra-Cellular Therapies is headquartered in Bedminster, New Jersey.

What is Intra-Cellular Therapies’ revenue?

Intra-Cellular Therapies disclosed revenue of 462M USD for 2023 and 249M USD for 2022.

How many employees does Intra-Cellular Therapies have?

Intra-Cellular Therapies has 610 employees.

What sector is Intra-Cellular Therapies in?

Intra-Cellular Therapies is a life science company.

When was Intra-Cellular Therapies founded?

Intra-Cellular Therapies was founded in 2002.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Subscribe to Mergr to view all 108 acquisitions of life science companies in 2025, including 5 acquisitions by private equity firms, and 103 by strategics.

Intra-Cellular Therapies

Intra-Cellular Therapies, Inc.

135 Route 202/206, Suite 6,
Bedminster, New Jersey 07921
United States,
(646) 440-9333
www.intracellulartherapies.com

Intra-Cellular Therapies is a biopharmaceutical company. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. Intra-Cellular Therapies was founded in 2002 and is based in Bedminster, New Jersey.


Company Summary

SECTOR

Life Science

Revenue

462   86% 2023
249   204% 2022
82   257% 2021
23   2020
(millions of USD) Show More Show Less

Employees

610

Established

2002

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Intra-Cellular Therapies

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal